H19 and in situ carcinoma: Serum H19 could be a potential biomarker for distinguishing hypertensive CIS cases from healthy control subjects with an AUC of 1 (95% CI = 1–1) at p < 0.0001, conferring 100% sensitivity and 100% specificity at a cutoff value of 1.24 (Figure 3A).